Cite
Acetazolamide-based [18F]-PET tracer: In vivo validation of carbonic anhydrase IX as a sole target for imaging of CA-IX expressing hypoxic solid tumors.
MLA
More, Kunal N., et al. “Acetazolamide-Based [18F]-PET Tracer: In Vivo Validation of Carbonic Anhydrase IX as a Sole Target for Imaging of CA-IX Expressing Hypoxic Solid Tumors.” Bioorganic & Medicinal Chemistry Letters, vol. 28, no. 5, Mar. 2018, pp. 915–21. EBSCOhost, https://doi.org/10.1016/j.bmcl.2018.01.060.
APA
More, K. N., Lee, J. Y., Kim, D.-Y., Cho, N.-C., Pyo, A., Yun, M., Kim, H. S., Kim, H., Ko, K., Park, J.-H., & Chang, D.-J. (2018). Acetazolamide-based [18F]-PET tracer: In vivo validation of carbonic anhydrase IX as a sole target for imaging of CA-IX expressing hypoxic solid tumors. Bioorganic & Medicinal Chemistry Letters, 28(5), 915–921. https://doi.org/10.1016/j.bmcl.2018.01.060
Chicago
More, Kunal N., Jun Young Lee, Dong-Yeon Kim, Nam-Chul Cho, Ayoung Pyo, Misun Yun, Hyeon Sik Kim, et al. 2018. “Acetazolamide-Based [18F]-PET Tracer: In Vivo Validation of Carbonic Anhydrase IX as a Sole Target for Imaging of CA-IX Expressing Hypoxic Solid Tumors.” Bioorganic & Medicinal Chemistry Letters 28 (5): 915–21. doi:10.1016/j.bmcl.2018.01.060.